The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of bemcentinib (BGB324), a first-in-class highly selective AXL inhibitor, with pembrolizumab in pts with advanced NSCLC: OS for stage I and preliminary stage II efficacy.
 
Enriqueta Felip
No Relationships to Disclose
 
Paal Brunsvig
No Relationships to Disclose
 
Nuria Vinolas
No Relationships to Disclose
 
Santiago Ponce Aix
No Relationships to Disclose
 
Enric Carcereny Costa
No Relationships to Disclose
 
Manuel Dómine Gomez
No Relationships to Disclose
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Edurne Arriola
No Relationships to Disclose
 
Rosario Garcia Campelo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche; Takeda
 
James F. Spicer
Stock and Other Ownership Interests - IGEA
Consulting or Advisory Role - Achilles Therapeutics (Inst); Bristol-Myers Squibb (Inst); Shionogi (Inst)
Research Funding - BerGenBio (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Genmab (Inst); Roche (Inst); Starpharma (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IO Biotech; Lytix Biopharma
 
Jonathan Robert Thompson
No Relationships to Disclose
 
Ana Laura Ortega Granados
No Relationships to Disclose
 
Robert J Holt
Employment - BerGenBio
 
Katherine Lorens
Employment - BerGenBio
 
James B. Lorens
Employment - BerGenBio
Leadership - BerGenBio
Stock and Other Ownership Interests - BerGenBio
Research Funding - BerGenBio
Patents, Royalties, Other Intellectual Property - BergGenBio ASA
 
Muhammad Shoaib
Consulting or Advisory Role - BerGenBio
 
Abdul Siddiqui
Consulting or Advisory Role - BerGenBio
 
Emmett V. Schmidt
Employment - Merck Sharp & Dome
 
Michael Jon Chisamore
Employment - Merck Sharp & Dome
 
Matthew Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Janssen; Octimet; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BerGenBio